Repair Biotechnologies
Pre-clinicalHuman cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading Platform (CDP) therapy solves this.
Founded
2018
Focus
Cell & Gene Therapy
About
Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading Platform (CDP) therapy solves this.
Funding History
2Total raised: $2.3M
Grant$250KLife Extension FoundationJun 15, 2019
Seed$2MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationIthaca, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile